Oncology
Consultant – Medical Oncology18+ Years
Fortis Hospitals
Mumbai
Dr. Amol Balvant Akhade is a Consultant Medical Oncologist and Haemato-Oncologist at Fortis Hospital, Mulund, Mumbai. With over 18 years of reported experience, he specialises in the medical management of solid tumours and haematological malignancies. His clinical practice includes chemotherapy, immunotherapy, targeted therapies, cancer treatment planning and the multidisciplinary management of patients with different types of cancer.
Dr. Amol Akhade holds an MBBS, MD in General Medicine and DM in Medical Oncology. He received specialised oncology training at Tata Memorial Hospital, Mumbai. His medical education and advanced training provide a foundation in systemic cancer treatment, management of treatment-related complications and the care of patients with complex malignant diseases.
His areas of clinical expertise include breast cancer, lung cancer, head and neck cancers, gastrointestinal cancers and gynaecological malignancies. As a haemato-oncologist, he also manages blood cancers such as lymphoma, leukaemia and multiple myeloma. Treatment selection depends on cancer stage, pathology, molecular characteristics, previous therapy and the patient's overall health.
Dr. Akhade has documented expertise in chemotherapy, immunotherapy and targeted cancer therapies. These approaches may be used individually or in combination, depending on the type of cancer and its biological characteristics. He also has experience in autologous and allogeneic bone marrow transplantation for selected haematological conditions, working within specialised multidisciplinary transplant care pathways.
In addition to clinical responsibilities, Dr. Amol Balvant Akhade participates in multidisciplinary tumour boards, medical education and oncology research. Fortis Healthcare identifies him as DNB faculty and reports his involvement in clinical trials and real-world oncology research. His academic work supports continued engagement with developments in evidence-based cancer care.
Patients seeking medical oncology consultation in Mumbai for solid tumours, blood cancers, chemotherapy, immunotherapy, targeted treatment or stem cell transplantation may consult Dr. Amol Akhade at Fortis Hospital, Mulund. A comprehensive oncology consultation involves reviewing medical records, pathology findings, imaging, previous treatment and individual goals before recommending an appropriate management plan.
Chemotherapy uses anti-cancer medicines to destroy cancer cells or inhibit their growth. It may be recommended before surgery, after surgery or for advanced cancers. The treatment schedule depends on cancer type, stage and patient health. Regular monitoring helps identify side effects and assess treatment response.
Immunotherapy helps the body's immune system recognise or attack certain cancer cells. Immune checkpoint inhibitors may be used for selected cancers based on diagnosis and biomarker results. Treatment requires specialist supervision because immune-related complications can affect organs such as the lungs, liver, bowel and endocrine glands.
Targeted therapy uses medicines designed to interfere with specific molecules involved in cancer growth or survival. These treatments may be considered when laboratory testing identifies suitable genetic or molecular features. Targeted medicines are used in several solid tumours and blood cancers, with monitoring tailored to the medication.
Medical treatment for breast cancer may include chemotherapy, hormone therapy, targeted therapy or immunotherapy. The recommended approach depends on tumour stage, hormone receptor status, HER2 status and other clinical findings. Systemic treatment may be used before or after surgery or to control advanced disease.
Medical management of lung cancer includes chemotherapy, immunotherapy and molecularly targeted medications in appropriately selected patients. Treatment depends on whether the cancer is small-cell or non-small-cell, its stage and biomarker findings. A multidisciplinary team may combine drug treatment with surgery or radiotherapy where indicated.
Head and neck cancers can affect the mouth, throat, larynx and surrounding structures. Medical oncology treatment may involve chemotherapy, immunotherapy or targeted therapy depending on the cancer type and stage. Systemic therapies are often coordinated with surgery and radiation treatment to achieve the patient's therapeutic goals.
Gastrointestinal cancers include malignancies of the stomach, colon, rectum and other digestive organs. Medical management may involve chemotherapy, targeted medications or immunotherapy in selected cases. Treatment planning considers tumour location, disease stage, pathology, molecular testing and the patient's general health.
Gynaecological cancers include ovarian, cervical, endometrial and other reproductive tract malignancies. Systemic treatment may include chemotherapy, targeted therapy and immunotherapy in selected circumstances. Medical oncologists coordinate with gynaecological surgeons and radiation oncologists to develop treatment plans suited to the cancer diagnosis and stage.
Leukaemia is a group of cancers affecting blood-forming cells, commonly involving the bone marrow and blood. Management varies according to whether the condition is acute or chronic and its molecular characteristics. Treatment may involve chemotherapy, targeted medicines, immunotherapy or stem cell transplantation in appropriately selected patients.
Lymphoma develops from lymphocytes and includes Hodgkin and non-Hodgkin lymphoma. Treatment depends on lymphoma subtype, stage and patient factors. Depending on the diagnosis, therapy may include chemotherapy, antibody-based treatments, targeted medicines, radiotherapy or stem cell transplantation for selected cases.
Multiple myeloma is a cancer of plasma cells that can affect bones, kidneys and blood cell production. Treatment often includes combinations of targeted medicines, immunomodulatory drugs and corticosteroids. Autologous stem cell transplantation may be considered for eligible patients, alongside supportive care and ongoing disease monitoring.
Autologous stem cell transplantation uses a patient's own previously collected blood-forming stem cells after intensive therapy. It is used for selected blood cancers, including multiple myeloma and certain lymphomas. The procedure requires specialised assessment, infection prevention, supportive care and monitoring during recovery.
Allogeneic stem cell transplantation uses blood-forming stem cells from a compatible donor. It may be considered for selected leukaemias and other haematological disorders. Treatment requires detailed donor matching, conditioning therapy, infection precautions and monitoring for complications such as graft-versus-host disease.
Precision oncology uses tumour characteristics, molecular testing and other clinical information to guide cancer treatment decisions. Certain genetic alterations or biomarkers may indicate suitability for specific targeted medicines or immunotherapies. Not every cancer has an actionable biomarker, so testing and treatment choices require individual assessment.
MBBS, MD (General Medicine), DM (Medical Oncology)
Cancer Chemotherapy, Immunotherapy, Targeted Cancer Therapy, Precision Oncology, Breast Cancer Treatment, Lung Cancer Treatment, Head and Neck Cancer Management, Gastrointestinal Cancer Treatment, Gynaecological Cancer Medical Management, Leukaemia Treatment, Lymphoma Treatment, Multiple Myeloma Management, Haemato-Oncology, Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Geriatric Oncology, Cancer Treatment Planning, Chemotherapy Side-Effect Management, Multidisciplinary Cancer Care.
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Amol Balvant Akhade
Dr. Amol Balvant Akhade is a Consultant Medical Oncologist and Haemato-Oncologist at Fortis Hospital, Mulund, Mumbai, specialising in solid tumours, blood cancers and systemic cancer treatment.
He holds MBBS, MD in General Medicine and DM in Medical Oncology. He has received specialist training at Tata Memorial Hospital, Mumbai.
Fortis Healthcare reports 18 years of experience, and Cancer Rounds describes more than 18 years.
His documented expertise includes breast, lung, head and neck, gastrointestinal and gynaecological cancers, together with lymphoma, leukaemia and multiple myeloma.
Yes. Immunotherapy is included in his documented medical oncology expertise. Eligibility depends on cancer type, stage, biomarkers and clinical circumstances.
Contact us for personalized help or to schedule an appointment.